- Home
- ROST vs TAK Comparison
ROST vs TAK Comparison
Compare ROST & TAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ROST | TAK |
|---|---|---|
| Founded | 1982 | 1781 |
| Country | United States | Japan |
| Employees | N/A | N/A |
| Industry | Clothing/Shoe/Accessory Stores | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 72.4B | 59.8B |
| IPO Year | 1994 | 2007 |
Fundamental Metrics
Financial Performance| Metric | ROST | TAK |
|---|---|---|
| Price | $233.80 | $20.40 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 20 | 3 |
| Target Price | ★ $268.00 | $22.72 |
| AVG Volume (30 Days) | 1.8M | ★ 2.4M |
| Earning Date | 11-19-2026 | 10-29-2026 |
| Dividend Yield | 0.78% | ★ 2.43% |
| EPS Growth | ★ 4.59 | N/A |
| EPS | ★ 4.69 | N/A |
| Revenue | ★ $22,750,559,000.00 | N/A |
| Revenue This Year | $12.99 | $4.35 |
| Revenue Next Year | $6.76 | $2.00 |
| P/E Ratio | $48.78 | ★ $41.25 |
| Revenue Growth | ★ 7.67 | N/A |
| 52 Week Low | $157.39 | $12.99 |
| 52 Week High | $257.00 | $20.39 |
Technical Indicators
Market Signals| Indicator | ROST | TAK |
|---|---|---|
| Relative Strength Index (RSI) | 52.08 | 71.51 |
| Support Level | $223.44 | $17.58 |
| Resistance Level | $239.98 | N/A |
| Average True Range (ATR) | 5.12 | 0.28 |
| MACD | 0.50 | 0.16 |
| Stochastic Oscillator | 62.77 | 93.11 |
Price Performance
Historical ComparisonAbout ROST Ross Stores Inc.
Ross Stores, founded in 1982, is a US-focused off-price apparel and home fashion retailer operating more than 2,100 stores across 43 states, primarily under the Ross Dress for Less banner, with a smaller footprint through dd's Discounts. In fiscal 2025, the company generated over $22 billion in sales. Ross offers branded apparel, footwear, accessories, and home goods at a 20%-60% discount to department and specialty store prices, sourcing closeouts and excess inventory from vendors worldwide.
About TAK Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.5 trillion in fiscal 2025. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with about 50% from the US, 10% from Japan, 25% from Europe, and 15% from Canada.